Granules India gains on getting approval for Acetaminophen, Aspirin and Caffeine Tablets

24 Feb 2021 Evaluate

Granules India is currently trading at Rs. 324.15, up by 2.30 points or 0.71% from its previous closing of Rs. 321.85 on the BSE.

The scrip opened at Rs. 322.00 and has touched a high and low of Rs. 329.00 and Rs. 319.05 respectively. So far 122535 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 438.00 on 01-Dec-2020 and a 52 week low of Rs. 114.50 on 23-Mar-2020.

Last one week high and low of the scrip stood at Rs. 344.80 and Rs. 315.10 respectively. The current market cap of the company is Rs. 7933.02 crore.

The promoters holding in the company stood at 42.04%, while Institutions and Non-Institutions held 26.70% and 31.27% respectively.

Granules India has received approval from the US Food & Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC). It is bioequivalent to the reference listed drug product (RLD), Excedrin Migraine Tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare. The product would be manufactured at Hyderabad facility and is expected to be launched shortly.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

560.65 -5.90 (-1.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×